Atai Life Sciences
ATAI is a global biotechnology company builder seeking to acquire and develop mental health treatments. The Berlin-based company. Atai Life Sciences The Next Unicorn Of The Psychedelics Sector Mushroomstocks Mushroomstocks ATAI Life Sciences a biopharmaceutical company aiming to make psychedelic drugs to treat mental health disorders announced that it is planning to. Atai life sciences . ATAI Life Sciences owns a large stake in Compass Pathways after investing in their Series A round. Atai Life Sciences atai or the Company a clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic compounds. Operator of a biotechnology company intended to develop drugs for anxiety and depression treatment. Psychedelic drugmaker ATAI Life Science which backed by billionaire investor Peter Thiel said it is planning to raise 100 million in an initial public offering. The Berlin-based biotech firm filed Tuesday with the SEC to raise 100 million in. ATAI Life Sciences